Chapter 7: Breast Cancer Liquid Biopsy Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.1.2. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.1.3. U.S. Breast Cancer Liquid Biopsy Market, by Application
7.2.2.2. Canada
7.2.2.2.1. Canada Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.2.2. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.2.3. Canada Breast Cancer Liquid Biopsy Market, by Application
7.2.2.3. Mexico
7.2.2.3.1. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.3.2. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.3.3. Mexico Breast Cancer Liquid Biopsy Market, by Application
7.2.3. North America Market Size and Forecast, by Product & Service
7.2.4. North America Market Size and Forecast, by Circulating Biomarker
7.2.5. North America Market Size and Forecast, by Application
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Country
7.3.2.1. Germany
7.3.2.1.1. Germany Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.1.2. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.1.3. Germany Breast Cancer Liquid Biopsy Market, by Application
7.3.2.2. France
7.3.2.2.1. France Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.2.2. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.2.3. France Breast Cancer Liquid Biopsy Market, by Application
7.3.2.3. UK
7.3.2.3.1. UK Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.3.2. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.3.3. UK Breast Cancer Liquid Biopsy Market, by Application
7.3.2.4. Italy
7.3.2.4.1. Italy Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.4.2. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.4.3. Italy Breast Cancer Liquid Biopsy Market, by Application
7.3.2.5. Spain
7.3.2.5.1. Spain Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.5.2. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.5.3. Spain Breast Cancer Liquid Biopsy Market, by Application
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.6.2. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.6.3. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application
7.3.3. Europe Market Size and Forecast, by Product & Service
7.3.4. Europe Market Size and Forecast, by Circulating Biomarker
7.3.5. Europe Market Size and Forecast, by Application
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.1.2. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.1.3. Japan Breast Cancer Liquid Biopsy Market, by Application
7.4.2.2. China
7.4.2.2.1. China Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.2.2. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.2.3. China Breast Cancer Liquid Biopsy Market, by Application
7.4.2.3. India
7.4.2.3.1. India Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.3.2. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.3.3. India Breast Cancer Liquid Biopsy Market, by Application
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.4.2. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.4.3. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application
7.4.3. Asia-Pacific Market Size and Forecast, by Product & Service
7.4.4. Asia-Pacific Market Size and Forecast, by Circulating Biomarker
7.4.5. Asia-Pacific Market Size and Forecast, by Application
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Latin America
7.5.2.1.1. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.1.2. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.1.3. Latin America Breast Cancer Liquid Biopsy Market, by Application
7.5.2.2. Middle East
7.5.2.2.1. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.2.2. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.2.3. Middle East Breast Cancer Liquid Biopsy Market, by Application
7.5.2.3. Africa
7.5.2.3.1. Africa Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.3.2. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.3.3. Africa Breast Cancer Liquid Biopsy Market, by Application
7.5.3. LAMEA Market Size and Forecast, by Product & Service
7.5.4. LAMEA Market Size and Forecast, by Circulating Biomarker
7.5.5. LAMEA Market Size and Forecast, by Application
List of Tables
Table 01. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 02. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 03. Reagent Kits Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 04. Reagent Kits Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 05. Instruments Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 06. Instruments Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 07. Service Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 08. Service Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 09. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 10. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 11. Circulating Tumor Cells Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 12. Circulating Tumor Cells Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 13. Extracellular Vesicles Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 14. Extracellular Vesicles Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 15. Circulating Tumor Dna Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 16. Circulating Tumor Dna Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 17. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 18. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 19. Diagnostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 20. Diagnostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 21. Prognostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 22. Prognostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 23. Risk Assessment Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 24. Risk Assessment Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 25. Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 26. Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 27. North America Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 28. North America Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 29. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 30. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 31. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 32. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 33. U.S. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 34. U.S. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 35. Canada Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 36. Canada Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 37. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 38. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 39. Canada Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 40. Canada Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 41. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 42. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 43. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 44. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 45. Mexico Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 46. Mexico Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 47. North America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 48. North America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 49. North America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 50. North America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 51. North America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 52. North America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 53. Europe Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 54. Europe Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 55. Germany Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 56. Germany Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 57. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 58. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 59. Germany Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 60. Germany Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 61. France Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 62. France Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 63. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 64. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 65. France Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 66. France Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 67. UK Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 68. UK Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 69. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 70. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 71. UK Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 72. UK Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 73. Italy Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 74. Italy Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 75. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 76. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 77. Italy Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 78. Italy Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 79. Spain Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 80. Spain Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 81. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 82. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 83. Spain Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 84. Spain Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 85. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 86. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 87. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 88. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 89. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 90. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 91. Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 92. Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 93. Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 94. Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 95. Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 96. Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 97. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 98. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 99. Japan Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 100. Japan Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 101. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 102. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 103. Japan Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 104. Japan Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 105. China Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 106. China Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 107. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 108. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 109. China Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 110. China Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 111. India Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 112. India Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 113. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 114. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 115. India Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 116. India Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 117. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 118. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 119. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 120. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 121. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 122. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 123. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 124. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 125. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 126. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 127. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 128. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 129. LAMEA Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 130. LAMEA Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 131. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 132. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 133. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 134. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 135. Latin America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 136. Latin America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 137. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 138. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 139. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 140. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 141. Middle East Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 142. Middle East Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 143. Africa Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 144. Africa Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 145. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 146. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 147. Africa Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 148. Africa Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 149. LAMEA Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 150. LAMEA Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 151. LAMEA Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 152. LAMEA Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 153. LAMEA Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 154. LAMEA Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 155. Biocept: Company Snapshot
Table 156. Biocept: Product Portfolio
Table 157. Biocept: Key Strategic Moves and Developments
Table 158. Roche: Company Snapshot
Table 159. Roche: Operating Segment
Table 160. Roche: Product Portfolio
Table 161. Roche: Key Strategic Moves and Developments
Table 162. Fluxion: Company Snapshot
Table 163. Fluxion: Product Portfolio
Table 164. Menarini: Company Snapshot
Table 165. Menarini: Product Portfolio
Table 166. Menarini: Key Strategic Moves and Developments
Table 167. Myriad: Company Snapshot
Table 168. Myriad: Operating Segments
Table 169. Myriad: Product Portfolio
Table 170. Neogenomics: Company Snapshot
Table 171. Neogenomics: Operating Segment
Table 172. Neogenomics: Product Portfolio
Table 173. Neogenomics: Key Strategic Moves and Developments
Table 174. Qiagen: Company Snapshot
Table 175. Qiagen: Operating Segment
Table 176. Qiagen: Product Portfolio
Table 177. Qiagen: Key Strategic Moves and Developments
Table 178. Sysmex: Company Snapshot
Table 179. Sysmex: Oerating Segment
Table 180. Sysmex.: Product Portfolio
Table 181. Thermo Fisher: Company Snapshot
Table 182. Thermo Fisher.: Operating Segment
Table 183. Thermo Fisher.: Product Portfolio
Table 184. Guardant: Company Snapshot
Table 185. Guardant: Operating Segment
Table 186. Guardant: Product Portfolio
Table 187. Guardant: Key Strategic Moves and Developments
List of Figures
Figure 01. Top Investment Pockets
Figure 02. Top Winning Strategies, by Year, 2017-2020*
Figure 03. Top Winning Strategies, by Development, 2017-2020* (%)
Figure 04. Top Winning Strategies, by Company, 2017-2020* (%)
Figure 05. Top Player Positioning, 2019
Figure 01. Value Chain Analysis of Pharmaceutical Packaging Market
Figure 02. Moderate Bargaining Power of Buyers
Figure 03. Moderate Bargaining Power of Suppliers
Figure 04. Moderate Threat of New Entrants
Figure 05. Moderate Threat of Substitution
Figure 06. High Competitive Rivalry
Figure 07. Impact Analysis:
Figure 08. Comparative Share Analysis of Plastic Bottle Market, by Country, 2019 & 2027(%)
Figure 09. Comparative Share Analysis of Parenteral Containers Market, by Country, 2019 & 2027(%)
Figure 10. Comparative Share Analysis of Blister Packaging Market, by Country, 2019 & 2027(%)
Figure 11. Comparative Share Analysis of Specialty Bags Market, by Country, 2019 & 2027(%)
Figure 12. Comparative Share Analysis of Closures Market, by Country, 2019 & 2027(%)
Figure 13. Comparative Share Analysis of Labels Market, by Country, 2019 & 2027(%)
Figure 14. Comparative Share Analysis of Others Market, by Country, 2019 & 2027(%)
Figure 15. Comparative Share Analysis of Glass Market, by Country, 2019 & 2027(%)
Figure 16. Comparative Share Analysis of Aluminium Foil Market, by Country, 2019 & 2027(%)
Figure 17. Comparative Share Analysis of Plastics and Polymers Market, by Country, 2019 & 2027(%)
Figure 18. Comparative Share Analysis of Paper and Paperboard Market, by Country, 2019 & 2027(%)
Figure 19. Comparative Share Analysis of Others Market, by Country, 2019 & 2027(%)
Figure 20. U.S. Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 21. Canada Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 22. Mexico Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 23. Germany Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 24. France Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 25. UK Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 26. Italy Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 27. Spain Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 28. Rest of Europe Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 29. Japan Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 30. China Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 31. Australia Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 32. India Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 33. South Korea Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 34. Rest of Asia-Pcaific Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 35. Brazil Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 36. Saudi Arabia Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 37. South Africa Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 38. Rest of LAMEA Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 39. Amcor: Net Sales, 2018-2020 ($Million)
Figure 40. Amcor: Revenue Share by Segment, 2020 (%)
Figure 41. Amcor: Revenue Share by Region, 2020 (%)
Figure 42. Aptar: Net Sales, 2017-2019 ($Million)
Figure 43. Aptar: Revenue Share by Segment, 2019 (%)
Figure 44. Aptar: Revenue Share by Region, 2019 (%)
Figure 45. Bd: Net Sales, 2017-2019 ($Million)
Figure 46. Bd: Revenue Share by Segment, 2019 (%)
Figure 47. Bd: Revenue Share by Region, 2019 (%)
Figure 48. Berry: Net Sales, 2017-2019 ($Million)
Figure 49. Berry: Revenue Share by Segment, 2019 (%)
Figure 50. Berry: Revenue Share by Region, 2019 (%)
Figure 51. Catalent: Net Sales, 2018-2020 ($Million)
Figure 52. Catalent: Revenue Share by Segment, 2020 (%)
Figure 53. Catalent: Revenue Share by Region, 2020 (%)
Figure 54. Ccl: Net Sales, 2017-2019 ($Million)
Figure 55. Ccl: Revenue Share by Segment, 2019 (%)
Figure 56. Ccl: Revenue Share by Region, 2019 (%)
Figure 57. Gerresheimer: Net Sales, 2017-2019 ($Million)
Figure 58. Gerresheimer: Revenue Share by Segment, 2019 (%)
Figure 59. Gerresheimer: Revenue Share by Region, 2019 (%)
Figure 60. Nipro Group: Net Sales, 2018-2020 ($Million)
Figure 61. Nipro Group: Revenue Share by Segment, 2020 (%)
Figure 62. Nipro Group: Revenue Share by Region, 2020 (%)
Figure 63. Schott Ag: Net Sales, 2017-2019 ($Million)
Figure 64. Schott Ag: Revenue Share by Segment, 2019 (%)
Figure 65. Schott Ag: Revenue Share by Region, 2019 (%)
Figure 66. West: Net Sales, 2017-2019 ($Million)
Figure 67. West: Revenue Share by Segment, 2019 (%)
Figure 68. West: Revenue Share by Region, 2019 (%)